291 filings
Page 4 of 15
8-K
9rd3 enesfx3zbnxa
29 Oct 20
Genocea Provides Third Quarter 2020 Corporate Update
7:04am
8-K
enr93bkzgz2bjz3b b51
22 Sep 20
Genocea Announces FDA Acceptance of GEN-011 IND Application
7:36am
EFFECT
fcqwx0cydlt2t2m
31 Aug 20
Notice of effectiveness
12:15am
424B3
sm0c815w91hqhcu1f2
28 Aug 20
Prospectus supplement
4:29pm
UPLOAD
34vptk
26 Aug 20
Letter from SEC
12:00am
CORRESP
0h8esw3 tj
26 Aug 20
Correspondence with SEC
12:00am
8-K
66xp65 5uvvq5swr8
5 Aug 20
Departure of Directors or Certain Officers
4:02pm
D
us4n ga7yvy2
3 Aug 20
$79.88M in equity / options / securities to be acquired, sold $75.51M, 18 investors
4:43pm
8-K
lagdl lnmab
30 Jul 20
Regulation FD Disclosure
2:10pm
8-K
2a27kp0jdt6yh
30 Jul 20
Three of five patients achieved separate RECIST responses after GEN-009 administration
8:50am
8-K
29kufilc
23 Jul 20
Genocea Provides Second Quarter 2020 Corporate Update
7:06am
8-K
qzolcfz710czw2
22 Jul 20
Entry into a Material Definitive Agreement
4:52pm
8-K
evaq0uca4zp k0zfgg5
20 Jul 20
Genocea Biosciences Provides Clinical Update
9:23am
8-K
v5pqg9x fxu
6 Jul 20
Regulation FD Disclosure
6:04am
8-K/A
cba vaq8m0
19 Jun 20
Submission of Matters to a Vote of Security Holders
4:05pm
S-8
a3wkoev
2 Jun 20
Registration of securities for employees
4:12pm
8-K
xssnx pzwxw4c980
2 Jun 20
Amendments to Articles of Incorporation or Bylaws
4:02pm
8-K
s7ubl
22 May 20
Other Events
6:06am